Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
11/1995
11/22/1995EP0682670A1 Deoxygenation of cis vicinal diols
11/21/1995US5468898 Antiinflammatory agents, antiarthritic agents, treatment for gastrointestinal disorders, psoriasis
11/14/1995US5466806 Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
11/14/1995US5466696 Tacrine and cytochrome P450 oxidase inhibitors and methods of use
11/09/1995WO1995029929A1 Novel erythromycin derivatives, method for their preparation and their use as drugs
11/08/1995EP0680967A1 Erythromycin derivatives, their process of preparation and their use as medicaments
11/08/1995EP0680479A1 Method for converting a xanthine ring or derivatives thereof into dialkylamino-xanthine derivatives
11/08/1995CN1111244A Cyclopropane derivatives and antiviral agents containing the same
11/07/1995US5464826 Antitumor, anticarcinogenic agents, treatment of herpes
11/02/1995WO1995029176A1 Substituted 1,3-oxathiolanes with antiviral properties
11/02/1995WO1995029174A1 Process for the diastereoselective synthesis of nucleoside analogues
11/02/1995EP0679634A2 Method for producing a 3-oxo-propionic acid amide compound and substituted acetyl compound used therein
10/1995
10/31/1995CA2148193A1 Process for preparing 2-amino-6-chloropurine and 2-acylamino-6-chloropurines
10/26/1995WO1995028402A2 Preparation of purines
10/26/1995WO1995028387A1 Benzamide compound and medicinal use thereof
10/26/1995WO1995028160A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
10/24/1995US5461152 Carbocyclic nucleosides containing bicycle rings, oligonucleotides therefrom, process for their preparation, their use and intermediates
10/24/1995US5461059 Derivatives of terbutylphenyl-1-amino-4-hydroxybutane their preparation processes and the pharmaceutical compositions containing them
10/18/1995CN1110479A Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
10/17/1995US5459255 For incorporation into oligonucleotides, cleaving RNA site specifically
10/17/1995US5459147 Angeotensin-antagonistic effects; hypotensive, antiischemic, and antidiabetic agents, treating glaucoma
10/17/1995US5459144 Pharmaceutically active compounds
10/15/1995CA2163890A1 Dc-89 derivative
10/12/1995WO1995026972A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
10/12/1995WO1995026727A1 Use of xanthine derivatives for reducing the pathological hyper-reactivity of eosinophilic granulocytes, novel xanthine compounds and process for producing them
10/12/1995DE4411660A1 Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung The use of xanthine derivatives for reducing the pathological hyperreactivity eosinophilic granulocytes, new xanthine compounds and processes for their preparation
10/12/1995CA2187081A1 Use of xanthine derivatives for reducing the pathological hyper-reactivity of eosinophilic granulocytes, novel xanthine compounds and process for producing them
10/12/1995CA2186250A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
10/11/1995CN1109755A Antiviral, Highly water soluble, stable, crystalline salts of 2',3'-dideoxyinosine monohydrate 2',3',-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate
10/11/1995CN1029972C Selective adenosine receptor compounds
10/11/1995CN1029968C Process for preparation of N-heteroaryl-purin-6-amines and their use as medicaments
10/11/1995CN1029967C New xanthine derivatives
10/04/1995EP0675124A2 Purine derivatives and suppressants for inflammatory diseases
10/04/1995EP0675123A1 Cyclopropane derivatives and method of preparing the same
10/04/1995EP0674634A1 Process for preparing substituted 1,3-oxathiolanes with antiviral properties
10/03/1995US5455246 Treating neuropsychiatric disorders
10/01/1995CA2145955A1 Cyclopropane derivatives and method of preparing the same
09/1995
09/29/1995CA2145443A1 Purine derivatives and suppressants for inflammatory diseases
09/27/1995EP0674176A1 Electrochemiluminescent rhenium moieties and methods of production
09/27/1995EP0673938A2 Novel purine derivatives and pharmaceutically acceptable salts thereof
09/27/1995EP0673376A1 Novel bicyclic pyrimidine compounds, method for preparing same and pharmaceutical compositions containing said compounds.
09/26/1995US5453426 Sulfur-containing xanthine derivatives as adenosine antagonists
09/26/1995CA2145432A1 Purine derivatives and pharmaceutically acceptable salts thereof
09/20/1995EP0672701A1 PNA-synthesis using a base labile aminoprotecting group
09/20/1995EP0672700A1 PNA-synthesis using an aminoprotecting group which is labile against weak acids
09/20/1995EP0672661A1 Substituted N-ethyl-glycinderivatives for the preparation of PNA and PNA-/DNA hybrides
09/19/1995CA1337023C Process for separating and removing caffeine from raw coffee
09/14/1995WO1995024379A1 Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors
09/13/1995EP0265519B1 Electrochemiluminescent assays
09/12/1995US5449840 Viricides
09/06/1995EP0670163A1 Use of pentoxifylline for the manufacture of a medicament for the treatment of fibrosing or granulomatosing lung diseases
09/06/1995EP0669825A1 Hydroxyl-containing compounds
09/05/1995US5447933 Xanthine derivatives
09/05/1995CA1336903C 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives
08/1995
08/31/1995WO1995023148A1 Xanthine derivative
08/31/1995CA2161011A1 Xanthine derivatives
08/29/1995US5446046 1,3-dipropyl-8-(3-oxatricyclo(3,1,2,0(2,4-))oct6(7)-Yl)-xanthine used to treat cadiac arrhythmias
08/24/1995WO1995022546A1 Intracellular signalling mediators
08/24/1995WO1995022330A1 Antiviral agents
08/24/1995CA2183562A1 Intracellular signalling mediators
08/23/1995EP0667777A1 Xanthine derivatives for use as diuretics
08/22/1995US5444063 95% free of corresponding beta-L enantiomer; oral or parenteral administeration
08/16/1995EP0666749A1 ENANTIOMERICALLY PURE beta-D-DIOXOLANE NUCLEOSIDES WITH SELECTIVE ANTI-HEPATITIS B VIRUS ACTIVITY
08/10/1995WO1995021184A1 Substituted purines and oligonucleotide cross-linking
08/10/1995WO1995021161A1 Chloropyrimide intermediates
08/09/1995CN1106404A Synthetic process of new drug dosotheophylline
08/09/1995CN1106403A 3-hydroxy-4-hydroxymethyl-2-methylenecyclopentyl purines and pyrimidines
08/09/1995CN1106402A Hydrofuran derivant with pyrimidine or purine substituting group
08/08/1995US5440041 Acetal or ketal substituted xanthine compounds
08/08/1995US5440037 Method for production of 2-amino-6-halogenopurine derivatives
08/08/1995US5439907 Use of N9 morpholino derivatives of 7,8-disubstituted guanines
08/03/1995WO1995020589A1 Cell signaling inhibitors
08/03/1995WO1995020567A1 Codrugs as a method of controlled drug delivery
08/02/1995EP0665229A1 Process for the production of nucleic acid base derivatives
08/02/1995EP0664708A1 Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent
08/01/1995US5438132 Precipitating with hydrogen sulfide, purification, of a viricide
07/1995
07/27/1995WO1995019970A1 Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/27/1995WO1995019774A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/27/1995CA2177372A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/26/1995EP0664294A1 Production of nucleoside analogues
07/26/1995EP0664127A2 Pharmaceutical compositions containing isoquinoline derivatives
07/26/1995EP0640091A4 Synthesis of nucleotide monomers.
07/20/1995CA2140408A1 Production of nucleoside analogues
07/19/1995EP0662970A1 Process for the preparation of 2-amino-6-chloropurine
07/19/1995EP0662961A1 Process of synthesizing useful intermediates of substituted imidazole compounds
07/19/1995EP0662958A1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers
07/19/1995EP0662834A1 Novel epoxide-containing compounds
07/19/1995EP0662819A1 An antivirally active pharmaceutical oil-in-water emulsion containing 9- (2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof.
07/18/1995US5434263 Process for the preparation of 2-acylamino-6-halopurine from 2,9-diacylguanine
07/18/1995US5434150 Anticoagulants, cardiovascular disorders
07/13/1995WO1995018820A1 Monomeric diols and phosphate linked oligomers formed therefrom
07/13/1995WO1995018792A1 Pyrrolidine-containing monomers and oligomers
07/13/1995WO1995018623A1 Oligomeric compounds having nitrogen-containing linkages
07/13/1995CA2181082A1 Oligomeric compounds having nitrogen-containing linkages
07/11/1995CA2015325C Fluorescent dye
07/06/1995WO1995017903A1 Modular design and synthesis of oxazolone-derived molecules
07/06/1995CA2179984A1 Modular design and synthesis of oxazolone-derived molecules
07/05/1995EP0660711A1 Novel use of inhibitors of phosphodiestersase iv
06/1995
06/29/1995WO1995017403A1 Guanine synthons for peptide nucleic acid synthesis and method for production
06/29/1995WO1995017190A1 Pharmaceuticals
1 ... 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 ... 120